Trade Shionogi & Co., Ltd. - 4507 CFD
Market information is presented
as of 2023-09-21
- Summary
| Spread | 44.0 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.010986% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.011237% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | JPY | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Japan | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Shionogi & Co Ltd ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
| Prev. Close* | 6822.1 |
| Open* | 6783.2 |
| 1-Year Change* | 17.2% |
| Day's Range* | 6783.2 - 6874.9 |
| 52 wk Range | 5,718.00-7,593.00 |
| Average Volume (10 days) | 1.05M |
| Average Volume (3 months) | 25.78M |
| Market Cap | 1,973.11B |
| P/E Ratio | 9.84 |
| Shares Outstanding | 294.31M |
| Revenue | 464.16B |
| EPS | 652.02 |
| Dividend (Yield %) | 2.10313 |
| Beta | 0.91 |
| Next Earnings Date | Oct 30, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jun 30, 2022 | 6828.0 | 44.8 | 0.66% | 6783.2 | 6874.9 | 6783.2 |
| Jun 29, 2022 | 6822.1 | -19.9 | -0.29% | 6842.0 | 6870.9 | 6811.1 |
| Jun 28, 2022 | 6837.0 | 109.7 | 1.63% | 6727.3 | 6843.0 | 6699.4 |
| Jun 27, 2022 | 6732.3 | 90.8 | 1.37% | 6641.5 | 6755.2 | 6641.5 |
| Jun 24, 2022 | 6698.4 | 308.3 | 4.82% | 6390.1 | 6701.4 | 6390.0 |
| Jun 23, 2022 | 6389.2 | 222.4 | 3.61% | 6166.8 | 6483.9 | 6089.9 |
| Jun 22, 2022 | 6771.2 | -1.0 | -0.01% | 6772.2 | 6847.0 | 6739.3 |
| Jun 21, 2022 | 6688.4 | 84.8 | 1.28% | 6603.6 | 6719.3 | 6557.7 |
| Jun 20, 2022 | 6559.7 | 6.0 | 0.09% | 6553.7 | 6589.7 | 6470.0 |
| Jun 17, 2022 | 6503.9 | 48.9 | 0.76% | 6455.0 | 6556.8 | 6453.0 |
| Jun 16, 2022 | 6633.6 | -20.9 | -0.31% | 6654.5 | 6754.2 | 6586.7 |
| Jun 15, 2022 | 6485.9 | -163.6 | -2.46% | 6649.5 | 6649.5 | 6459.0 |
| Jun 14, 2022 | 6716.3 | -4.0 | -0.06% | 6720.3 | 6740.3 | 6661.5 |
| Jun 13, 2022 | 6802.1 | -61.8 | -0.90% | 6863.9 | 6890.9 | 6763.2 |
| Jun 10, 2022 | 6990.6 | -24.9 | -0.35% | 7015.5 | 7037.5 | 6983.6 |
| Jun 9, 2022 | 7125.3 | -51.8 | -0.72% | 7177.1 | 7244.0 | 7104.3 |
| Jun 8, 2022 | 7100.3 | 153.6 | 2.21% | 6946.7 | 7100.3 | 6940.8 |
| Jun 7, 2022 | 6904.8 | 70.8 | 1.04% | 6834.0 | 6916.8 | 6834.0 |
| Jun 6, 2022 | 6842.0 | 52.9 | 0.78% | 6789.1 | 6850.0 | 6783.2 |
| Jun 3, 2022 | 6761.2 | 67.8 | 1.01% | 6693.4 | 6790.1 | 6693.4 |
Shionogi & Co., Ltd. Events
| Time (UTC) | Country | Event |
|---|---|---|
| Thursday, September 28, 2023 | ||
| Time (UTC) 12:00 | Country JP
| Event Shionogi & Co Ltd Shionogi & Co LtdForecast -Previous - |
| Monday, October 30, 2023 | ||
| Time (UTC) 04:00 | Country JP
| Event Q2 2024 Shionogi & Co Ltd Earnings Release Q2 2024 Shionogi & Co Ltd Earnings ReleaseForecast -Previous - |
| Monday, January 29, 2024 | ||
| Time (UTC) 04:00 | Country JP
| Event Q3 2024 Shionogi & Co Ltd Earnings Release Q3 2024 Shionogi & Co Ltd Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Total revenue | 426684 | 335138 | 297177 | 333371 | 367960 |
| Revenue | 426684 | 335138 | 297177 | 333371 | 367960 |
| Cost of Revenue, Total | 62246 | 55415 | 52523 | 56782 | 55591 |
| Gross Profit | 364438 | 279723 | 244654 | 276589 | 312369 |
| Total Operating Expense | 277681 | 224826 | 179739 | 202879 | 223635 |
| Selling/General/Admin. Expenses, Total | 93637 | 87877 | 88387 | 91802 | 85285 |
| Research & Development | 102392 | 72996 | 54249 | 47949 | 52058 |
| Unusual Expense (Income) | 10210 | 334 | 1286 | -1781 | 19272 |
| Other Operating Expenses, Total | 1305 | 814 | -23430 | 1580 | 4773 |
| Operating Income | 149003 | 110312 | 117438 | 130492 | 144325 |
| Interest Income (Expense), Net Non-Operating | 70502 | 16224 | 26157 | 29503 | 30936 |
| Other, Net | 827 | -268 | -577 | -1479 | -1218 |
| Net Income Before Taxes | 220332 | 126268 | 143018 | 158516 | 174043 |
| Net Income After Taxes | 184496 | 113439 | 112062 | 122194 | 136919 |
| Minority Interest | 469 | 746 | -203 | 1 | 272 |
| Net Income Before Extra. Items | 184965 | 114185 | 111859 | 122195 | 137191 |
| Net Income | 184965 | 114185 | 111859 | 122195 | 137191 |
| Total Adjustments to Net Income | -1 | -2 | 0 | ||
| Income Available to Common Excl. Extra. Items | 184965 | 114185 | 111858 | 122193 | 137191 |
| Income Available to Common Incl. Extra. Items | 184965 | 114185 | 111858 | 122193 | 137191 |
| Dilution Adjustment | |||||
| Diluted Net Income | 184965 | 114185 | 111858 | 122193 | 137191 |
| Diluted Weighted Average Shares | 297.805 | 301.579 | 306.554 | 309.13 | 315.576 |
| Diluted EPS Excluding Extraordinary Items | 621.094 | 378.624 | 364.888 | 395.28 | 434.732 |
| Dividends per Share - Common Stock Primary Issue | 135 | 115 | 108 | 103 | 94 |
| Diluted Normalized EPS | 649.802 | 379.619 | 368.175 | 390.839 | 482.775 |
| Depreciation / Amortization | 7858 | 7370 | 6724 | 6547 | 6656 |
| Interest Expense (Income) - Net Operating | 33 | 20 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 109311 | 88337 | 187568 | 78939 | 71839 |
| Revenue | 109311 | 88337 | 187568 | 78939 | 71839 |
| Cost of Revenue, Total | 13119 | 17680 | 17199 | 14421 | 12945 |
| Gross Profit | 96192 | 70657 | 170369 | 64518 | 58894 |
| Total Operating Expense | 62726 | 85807 | 69319 | 63137 | 59418 |
| Selling/General/Admin. Expenses, Total | 23191 | 27089 | 24168 | 24069 | 22447 |
| Research & Development | 24997 | 27584 | 26078 | 26198 | 22530 |
| Depreciation / Amortization | 849 | 846 | 923 | 995 | 956 |
| Other Operating Expenses, Total | 570 | 12608 | 951 | -2546 | 540 |
| Operating Income | 46585 | 2530 | 118249 | 15802 | 12421 |
| Interest Income (Expense), Net Non-Operating | 9119 | 19016 | 12559 | 11865 | 27889 |
| Other, Net | |||||
| Net Income Before Taxes | 55704 | 21546 | 130808 | 27667 | 40310 |
| Net Income After Taxes | 42214 | 26723 | 100366 | 22981 | 34426 |
| Minority Interest | 347 | 512 | 99 | -438 | 295 |
| Net Income Before Extra. Items | 42561 | 27235 | 100465 | 22543 | 34721 |
| Net Income | 42561 | 27235 | 100465 | 22543 | 34721 |
| Income Available to Common Excl. Extra. Items | 42562 | 27236 | 100464 | 22542 | 34722 |
| Income Available to Common Incl. Extra. Items | 42562 | 27236 | 100464 | 22542 | 34722 |
| Diluted Net Income | 42562 | 27236 | 100464 | 22542 | 34722 |
| Diluted Weighted Average Shares | 294.406 | 294.406 | 295.501 | 300.73 | 301.583 |
| Diluted EPS Excluding Extraordinary Items | 144.569 | 92.5117 | 339.979 | 74.9576 | 115.132 |
| Dividends per Share - Common Stock Primary Issue | 0 | 75 | 0 | 60 | 0 |
| Diluted Normalized EPS | 144.569 | 92.5117 | 339.979 | 74.9576 | 115.132 |
| Total Adjustments to Net Income | 1 | 1 | -1 | -1 | 1 |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Total Current Assets | 784192 | 659205 | 556238 | 516026 | 493645 |
| Cash and Short Term Investments | 563355 | 465177 | 418324 | 380018 | 346330 |
| Cash & Equivalents | 309224 | 184420 | 196173 | 208861 | 195800 |
| Short Term Investments | 254131 | 280757 | 222151 | 171157 | 150530 |
| Total Receivables, Net | 109842 | 123016 | 78211 | 79996 | 101346 |
| Accounts Receivable - Trade, Net | 109309 | 122544 | 77178 | 79345 | 100449 |
| Total Inventory | 57919 | 45892 | 38003 | 33818 | 35125 |
| Other Current Assets, Total | 53076 | 25120 | 21700 | 22194 | 10844 |
| Total Assets | 1311800 | 1150600 | 998992 | 873695 | 938540 |
| Property/Plant/Equipment, Total - Net | 118567 | 112417 | 95710 | 76007 | 76901 |
| Property/Plant/Equipment, Total - Gross | 295126 | 284453 | 262101 | 255228 | 252502 |
| Accumulated Depreciation, Total | -176559 | -172037 | -166391 | -179222 | -175601 |
| Goodwill, Net | 9819 | 9638 | 9357 | 7854 | 3358 |
| Intangibles, Net | 96309 | 81223 | 76558 | 51705 | 47804 |
| Long Term Investments | 274093 | 269151 | 244196 | 204657 | 302709 |
| Other Long Term Assets, Total | 28820 | 18967 | 16933 | 17446 | 14123 |
| Total Current Liabilities | 158552 | 124396 | 100180 | 81119 | 96149 |
| Accounts Payable | 14005 | 16372 | 9902 | 10763 | 9442 |
| Accrued Expenses | |||||
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 141533 | 105079 | 86899 | 66995 | 82483 |
| Total Liabilities | 211754 | 174940 | 152884 | 108543 | 129766 |
| Total Long Term Debt | 6397 | 3729 | 4608 | 4791 | 6006 |
| Long Term Debt | 0 | ||||
| Deferred Income Tax | 5916 | 7807 | 7749 | 1949 | 444 |
| Minority Interest | 21832 | 17624 | 18442 | 51 | 4313 |
| Other Liabilities, Total | 19057 | 21384 | 21905 | 20633 | 22854 |
| Total Equity | 1100050 | 975661 | 846108 | 765152 | 808774 |
| Common Stock | 21279 | 21279 | 21279 | 21279 | 21279 |
| Additional Paid-In Capital | 15204 | 14455 | 13733 | 21025 | 21277 |
| Retained Earnings (Accumulated Deficit) | 940606 | 832958 | 752248 | 708291 | 613483 |
| Treasury Stock - Common | -63074 | -57857 | -57989 | -77292 | -28882 |
| Unrealized Gain (Loss) | 1 | 1 | |||
| Other Equity, Total | 186030 | 164826 | 116837 | 91849 | 181616 |
| Total Liabilities & Shareholders’ Equity | 1311800 | 1150600 | 998992 | 873695 | 938540 |
| Total Common Shares Outstanding | 294.306 | 301.483 | 301.464 | 303.784 | 311.287 |
| Current Port. of LT Debt/Capital Leases | 3014 | 2945 | 3379 | 3361 | 4224 |
| Capital Lease Obligations | 6397 | 3729 | 4608 | 4791 | 6006 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 784192 | 749552 | 679927 | 683921 | 659205 |
| Cash and Short Term Investments | 563355 | 492065 | 488563 | 502804 | 465177 |
| Cash & Equivalents | 309224 | 218669 | 198043 | 204629 | 254420 |
| Short Term Investments | 254131 | 273396 | 290520 | 298175 | 210757 |
| Total Receivables, Net | 109842 | 164358 | 99719 | 98538 | 123016 |
| Accounts Receivable - Trade, Net | 109309 | 164334 | 99661 | 97928 | 122544 |
| Total Inventory | 57919 | 58688 | 56069 | 52061 | 45892 |
| Other Current Assets, Total | 53076 | 34441 | 35576 | 30518 | 25120 |
| Total Assets | 1311800 | 1261620 | 1195940 | 1200960 | 1150600 |
| Property/Plant/Equipment, Total - Net | 118567 | 115980 | 113527 | 114772 | 112417 |
| Goodwill, Net | 9819 | 10075 | 10077 | 9864 | 9638 |
| Intangibles, Net | 96309 | 108208 | 108494 | 97125 | 81223 |
| Long Term Investments | 274093 | 261888 | 266357 | 277129 | 269151 |
| Other Long Term Assets, Total | 28820 | 15913 | 17557 | 18146 | 18967 |
| Total Current Liabilities | 158552 | 145322 | 127003 | 129836 | 124396 |
| Accounts Payable | 14005 | 16780 | 17844 | 15579 | 16372 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3014 | 2778 | 2967 | 2971 | 2945 |
| Other Current Liabilities, Total | 141533 | 125764 | 106192 | 111286 | 105079 |
| Total Liabilities | 211754 | 206376 | 186360 | 186595 | 174940 |
| Total Long Term Debt | 6397 | 5879 | 3848 | 3675 | 3729 |
| Capital Lease Obligations | 6397 | 5879 | 3848 | 3675 | 3729 |
| Deferred Income Tax | 5916 | 8254 | 8877 | 8456 | 7807 |
| Minority Interest | 21832 | 23286 | 23414 | 22154 | 17624 |
| Other Liabilities, Total | 19057 | 23635 | 23218 | 22474 | 21384 |
| Total Equity | 1100050 | 1055240 | 1009580 | 1014360 | 975661 |
| Common Stock | 21279 | 21279 | 21279 | 21279 | 21279 |
| Additional Paid-In Capital | 15204 | 15204 | 15204 | 15204 | 14455 |
| Retained Earnings (Accumulated Deficit) | 940606 | 937461 | 853614 | 849226 | 832958 |
| Treasury Stock - Common | -63074 | -89349 | -63263 | -57858 | -57857 |
| Unrealized Gain (Loss) | 1 | 170645 | 182744 | 186510 | |
| Other Equity, Total | 186030 | 1 | 1 | 164826 | |
| Total Liabilities & Shareholders’ Equity | 1311800 | 1261620 | 1195940 | 1200960 | 1150600 |
| Total Common Shares Outstanding | 294.306 | 294.307 | 301.117 | 301.483 | 301.483 |
| Property/Plant/Equipment, Total - Gross | 295126 | 284453 | |||
| Accumulated Depreciation, Total | -176559 | -172037 |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 220332 | 126268 | 143018 | 158516 | 174043 |
| Cash From Operating Activities | 177866 | 102068 | 109039 | 131940 | 165000 |
| Cash From Operating Activities | 17165 | 16351 | 14779 | 14115 | 14431 |
| Amortization | |||||
| Non-Cash Items | -59703 | -15456 | -25011 | -29133 | 17168 |
| Cash Taxes Paid | 27284 | 26038 | 32254 | 48354 | 23499 |
| Cash Interest Paid | 94 | 87 | 256 | 348 | 33656 |
| Changes in Working Capital | 72 | -25095 | -23747 | -11558 | -40642 |
| Cash From Investing Activities | -48292 | -96204 | -5261 | -29144 | -56256 |
| Capital Expenditures | -37187 | -31564 | -32944 | -11768 | -25395 |
| Other Investing Cash Flow Items, Total | -11105 | -64640 | 27683 | -17376 | -30861 |
| Cash From Financing Activities | -84123 | -36615 | -43891 | -88174 | -89912 |
| Financing Cash Flow Items | 4716 | -2 | 8886 | -3349 | 1019 |
| Total Cash Dividends Paid | -36142 | -33146 | -32529 | -31122 | -27639 |
| Issuance (Retirement) of Stock, Net | -49539 | -14 | -16600 | -50159 | -50270 |
| Foreign Exchange Effects | 9352 | 8998 | 7425 | -1560 | 832 |
| Net Change in Cash | 54803 | -21753 | 67312 | 13062 | 19664 |
| Issuance (Retirement) of Debt, Net | -3158 | -3453 | -3648 | -3544 | -13022 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 220332 | 198786 | 67978 | 40310 | 126268 |
| Cash From Operating Activities | 177866 | 116387 | 58370 | 38249 | 102068 |
| Cash From Operating Activities | 17165 | 12950 | 8645 | 4300 | 16351 |
| Non-Cash Items | -59703 | -53546 | -39949 | -27091 | -15456 |
| Cash Taxes Paid | 27284 | 28042 | 12150 | 12132 | 26038 |
| Cash Interest Paid | 94 | 56 | 44 | 26 | 87 |
| Changes in Working Capital | 72 | -41803 | 21696 | 20730 | -25095 |
| Cash From Investing Activities | -48292 | -79298 | -90374 | -82474 | -96204 |
| Capital Expenditures | -37187 | -34488 | -31284 | -18330 | -31564 |
| Other Investing Cash Flow Items, Total | -11105 | -44810 | -59090 | -64144 | -64640 |
| Cash From Financing Activities | -84123 | -83633 | -38448 | -14221 | -36615 |
| Financing Cash Flow Items | 4716 | 4716 | 4716 | 4712 | -2 |
| Total Cash Dividends Paid | -36142 | -36164 | -18078 | -18089 | -33146 |
| Issuance (Retirement) of Stock, Net | -49539 | -49535 | -23355 | -1 | -14 |
| Issuance (Retirement) of Debt, Net | -3158 | -2650 | -1731 | -843 | -3453 |
| Foreign Exchange Effects | 9352 | 10793 | 14074 | 8654 | 8998 |
| Net Change in Cash | 54803 | -35751 | -56378 | -49792 | -21753 |
Shionogi & Co., Ltd. Company profile
About Shionogi & Co Ltd
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of information to contribute to medical care by maximizing its products. The over-the-counter (OTC) pharmaceutical business handles products tailored to customers' lifestyles. The in-vitro diagnostics business is engaged in the sale of products, as well as the provision of information on infectious diseases, cardiovascular diseases and allergic diseases. The Company mainly provides its products and services in Japan, Europe and North America markets.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Shionogi & Co Ltd revenues decreased 2% to Y219.62B. Net income applicable to common stockholders decreased 20% to Y71B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Other income decrease of 93% to Y1.74B (income), Research&Development Expenses-SGA increase of 23% to Y48.22B (expense).
Equity composition
FY'99-FY'02 WAS and FY'04 DPS were estimated. FY'05-'07 1&3Q WAS was estimated and used as O/S. FY'08 3Q WAS was estimated and used for O/S. FY'08 1Q & 3Q WAS=O/S.
| Industry: | Pharmaceuticals (NEC) |
道修町3丁目1番8号
中央区
OSAKA-SHI
OSAKA-FU 541-0045
JP
News
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com